Antioxidants in critical illness

被引：108

作者：

Bulger, EM ^{[1
]}

Maier, RV ^{[1
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA

来源：

ARCHIVES OF SURGERY | 2001年 / 136卷 / 10期

关键词：

D O I：

10.1001/archsurg.136.10.1201

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Oxidative stress has been implicated in the manifestations of critical illnesses, including ischemia and reperfusion injury and systemic inflammatory states. This review describes the evidence for increased oxidative stress in critically ill patients and explores the data regarding antioxidant therapy for these conditions. Antioxidant therapies reviewed include N-acetylcysteine, selenium, vitamins E and C, superoxide dismutase, catalase, lazaroids, and allopurinol. We focus on the results of these interventions in animal models and human trials, when available.

引用

页码：1201 / 1207

页数：7

共 95 条

[1] THE PROTECTIVE ACTION OF ALLOPURINOL IN AN EXPERIMENTAL-MODEL OF HEMORRHAGIC-SHOCK AND REPERFUSION [J].

ALLAN, G ;

CAMBRIDGE, D ;

LEETSANGTAN, L ;

VANWAY, CW ;

WHITING, MV .

BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (01) :149-155

[2] Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats [J].

Altavilla, D ;

Squadrito, F ;

Serrano, M ;

Campo, GM ;

Squadrito, G ;

Arlotta, M ;

Urna, G ;

Sardella, A ;

Saitta, A ;

Caputi, AP .

BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) :1293-1299

[3] Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome [J].

Angstwurm, MWA ;

Schottdorf, J ;

Schopohl, J ;

Gaertner, R .

CRITICAL CARE MEDICINE, 1999, 27 (09) :1807-1813

[4] THE ANTIOXIDANT ACTION OF N-ACETYLCYSTEINE - ITS REACTION WITH HYDROGEN-PEROXIDE, HYDROXYL RADICAL, SUPEROXIDE, AND HYPOCHLOROUS ACID [J].

ARUOMA, OI ;

HALLIWELL, B ;

HOEY, BM ;

BUTLER, J .

FREE RADICAL BIOLOGY AND MEDICINE, 1989, 6 (06) :593-597

[5]

AZZI A, 1993, VITAMIN E HLTH DIS

[6]

BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141

[7] A trial of antioxidants N-acetylcysteine and procysteine in ARDS [J].

Bernard, GR ;

Wheeler, AP ;

Arons, MM ;

Morris, PE ;

Paz, HL ;

Russell, JA ;

Wright, PE ;

Bernard, GR ;

Arons, MM ;

Wheeler, AP ;

Carmichael, LC ;

Morris, PE ;

Higgins, SB ;

Dupont, WD ;

Edens, TR ;

Swindell, BB ;

Russell, JA ;

Paz, HL ;

Wright, PE ;

Steinberg, KP .

CHEST, 1997, 112 (01) :164-172

[8] EFFECT OF N-ACETYLCYSTEINE ON THE PULMONARY RESPONSE TO ENDOTOXIN IN THE AWAKE SHEEP AND UPON INVITRO GRANULOCYTE FUNCTION [J].

BERNARD, GR ;

LUCHT, WD ;

NIEDERMEYER, ME ;

SNAPPER, JR ;

OGLETREE, ML ;

BRIGHAM, KL .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (06) :1772-1784

[9] DIFFERENCES IN TOCOPHEROL-LIPID RATIOS IN ARDS AND NON-ARDS PATIENTS [J].

BERTRAND, Y ;

PINCEMAIL, J ;

HANIQUE, G ;

DENIS, B ;

LEENAERTS, L ;

VANKEERBERGHEN, L ;

DEBY, C .

INTENSIVE CARE MEDICINE, 1989, 15 (02) :87-93

[10] Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk [J].

Borrelli, E ;

RouxLombard, P ;

Grau, GE ;

Girardin, E ;

Ricou, B ;

Dayer, JM ;

Suter, PM .

CRITICAL CARE MEDICINE, 1996, 24 (03) :392-397

← 1 2 3 4 5 6 7 8 9 10 →